Patent · US Active

Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C

US8999975B2 · kind B2 · utility

18Cited by

1References

7Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Marc Grundl · Biberach an der Riß, DE
Thorsten Oost · Biberach an der Riß, DE
Alexander Pautsch · Ulm, DE
Stefan Peters · Biberach an der Riß, DE
Doris Riether · Biberach an der Riß, DE
Wolfgang Wienen · Äpfingen, DE

Key dates

Filing date	Sep 14, 2012
Grant date	Apr 7, 2015
Priority date	—
Expiry date	Sep 14, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to compounds of Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.